Josh Abramson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Josh Abramson has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
Sukhdeep Singh
Google DeepMind, London, UK
5 shared publications- Zachary Wu
Core Contributor, Google DeepMind, London, UK
4 shared publications Akvilė Žemgulytė
Google DeepMind, London, UK
3 shared publicationsAlexander I. Cowen-Rivers
Google DeepMind, London, UK
3 shared publicationsAshok Thillaisundaram
Google DeepMind, London, UK
3 shared publications- Augustin Žídek
Google DeepMind, London, UK
3 shared publications
Latest Publications
- Open Access
Designing enzymes for new-to-nature chemistry and non-natural substrates with AlphaProtein Novo
Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences 1 . Traditional protein engineering 2,3 is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles 4 , but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 5 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.
Open AccessDesigning enzymes for new-to-nature chemistry and non-natural substrates with AlphaProtein Novo
Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences 1 . Traditional protein engineering 2,3 is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles 4 , but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 5 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.
- Open Access
Design-Evolution Synergy Enables New-to-Nature Enzyme Chemistry
Directed evolution and machine-learning-assisted evolution have transformed biocatalysis by enabling rapid optimisation of catalytic performance within compatible protein scaffolds. In parallel, advances in deep-learning-driven de novo protein design have expanded accessible protein architectural space, enabling the generation of functional catalysts for increasingly challenging transformations. We herein report a synergistic design-evolution strategy to encode new-to-nature regio- and enantioselective C–H amination reactions using engineered de novo haemproteins to synthesise chiral piperidines, a privileged pharmacophore in drug discovery. By integrating motif scaffolding, computational re-design, and directed evolution, we demonstrate de novo enzyme design can enable challenging, high-energy-barrier enzyme chemistry with programmable regio- and enantioselectivity, high catalytic efficiency, excellent enzyme stability, and scaffold diversity.
Open AccessDesign-Evolution Synergy Enables New-to-Nature Enzyme Chemistry
Directed evolution and machine-learning-assisted evolution have transformed biocatalysis by enabling rapid optimisation of catalytic performance within compatible protein scaffolds. In parallel, advances in deep-learning-driven de novo protein design have expanded accessible protein architectural space, enabling the generation of functional catalysts for increasingly challenging transformations. We herein report a synergistic design-evolution strategy to encode new-to-nature regio- and enantioselective C–H amination reactions using engineered de novo haemproteins to synthesise chiral piperidines, a privileged pharmacophore in drug discovery. By integrating motif scaffolding, computational re-design, and directed evolution, we demonstrate de novo enzyme design can enable challenging, high-energy-barrier enzyme chemistry with programmable regio- and enantioselectivity, high catalytic efficiency, excellent enzyme stability, and scaffold diversity.
- Open Access
- 30 September 2026
- Published by Springer Nature in Nature
- p. 1-9
Function-preserving watermarking of AI-generated proteins
Generative artificial intelligence (AI) models are revolutionizing biology, with tools such as AlphaFold 3 and protein design models accelerating breakthroughs in protein structure prediction and the creation of new functional proteins 1 . Tracking and establishing the provenance of AI-generated protein sequences and structures is becoming increasingly important to tackle a range of emerging challenges, including biosecurity and concerns about information veracity 2–4 . Here we introduce SynthIDBio, a family of methods for watermarking protein sequences and structures to establish the provenance of those generated with AI. SynthIDBio-sequence actively embeds a watermark into protein sequences while preserving function. We demonstrate this by creating watermarked, functional designed protein binders with binding affinity comparable with non-watermarked counterparts and near-perfect watermark detection accuracy. Furthermore, SynthIDBio-structure, a fine-tuned AlphaFold3 model, embeds an imperceptible watermark into biomolecular structures. Our work is a proof-of-concept that function-preserving biological watermarking is feasible, introducing a potential tool for provenance in the rapidly expanding era of AI-driven biological engineering.
- 30 September 2026
- Published by Springer Nature in Nature
- p. 1-9
Open AccessFunction-preserving watermarking of AI-generated proteins
Generative artificial intelligence (AI) models are revolutionizing biology, with tools such as AlphaFold 3 and protein design models accelerating breakthroughs in protein structure prediction and the creation of new functional proteins 1 . Tracking and establishing the provenance of AI-generated protein sequences and structures is becoming increasingly important to tackle a range of emerging challenges, including biosecurity and concerns about information veracity 2–4 . Here we introduce SynthIDBio, a family of methods for watermarking protein sequences and structures to establish the provenance of those generated with AI. SynthIDBio-sequence actively embeds a watermark into protein sequences while preserving function. We demonstrate this by creating watermarked, functional designed protein binders with binding affinity comparable with non-watermarked counterparts and near-perfect watermark detection accuracy. Furthermore, SynthIDBio-structure, a fine-tuned AlphaFold3 model, embeds an imperceptible watermark into biomolecular structures. Our work is a proof-of-concept that function-preserving biological watermarking is feasible, introducing a potential tool for provenance in the rapidly expanding era of AI-driven biological engineering.
- Top Cited PapersOpen Access
- 27 November 2024
- Published by Springer Nature in Nature
- Vol. 636 (8042) , E4
Addendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3
- 27 November 2024
- Published by Springer Nature in Nature
- Vol. 636 (8042) , E4
Top Cited PapersOpen AccessAddendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3
- Top Cited PapersOpen Access
- 8 May 2024
- Published by Springer Nature in Nature
- Vol. 630 (8016) , 493-500
Accurate structure prediction of biomolecular interactions with AlphaFold 3
The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2–6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein–ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein–nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody–antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework.
- 8 May 2024
- Published by Springer Nature in Nature
- Vol. 630 (8016) , 493-500
Top Cited PapersOpen AccessAccurate structure prediction of biomolecular interactions with AlphaFold 3
The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2–6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein–ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein–nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody–antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework.